Atlas Trials

Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease

Clinical trial NCT00109291 · TERMINATED

Trial details

NCT number
NCT00109291
Sponsor
Affymax
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
AnemiaChronic Kidney DiseaseChronic Renal Failure
Start date
2005-03-01
Primary completion
2006-02-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.